Download biomedica product list
World Osteoporosis Day – Supporting Bone Health Research
About Osteoporosis
Osteoporosis is a bone condition where bone loss progresses gradually without symptoms until a fracture occurs. It develops when bone mineral density and bone strength decline, making bones more fragile and more likely to break (1, 2 ).
Worldwide, osteoporosis and related fragility fractures are a major public health concern. About 1 in 3 women and 1 in 5 men over age 50 will experience an osteoporotic fracture, and up to 37 million fragility fractures occur globally each year among people over 55 (3, 4).
World Osteoporosis Day – Supporting Bone Health Research
Learn about THE 5 STEPS TO HEALTHY BONES AND A FRACTURE-FREE FUTURE : About Osteoporosis | World Osteoporosis Day
At Biomedica, our bone biomarker ELISA kits support researchers in measuring key regulatory markers of bone metabolism, helping provide valuable insights into bone formation, bone resorption, and disease progression.
Biomedica ELISA Assay kit box and reagent set
Sclerostin (SOST) ELISA (BI-20492)
o Most internationally referenced Sclerostin ELISA with more than 340 citations
o Low sample volume – 20µl / well
o Full validation package
Bioactive Sclerostin ELISA (BI-20472)
o Targets the receptor binding region
o Full validation package
o Low sample volume – 20 µl of serum/plasma per well
Dickkopf-1 (DKK-1) ELISA (BI-20413)
o Widely cited +190 publications
o Direct measurement
o Validated following international quality guidelines
Osteoprotegerin (OPG) ELISA (BI-20403)
o most referenced human OPG ELISA in +280 citations
o day test, ready to use color coded reagents
o controls included
Free soluble RANKL ELISA (BI-20462)
o Highly sensitive – measurable concentrations in healthy subjects
o Only assay measuring free, uncomplexed soluble RANKL
o Cited in over +330 citations
o for serum and plasma samples
o full validation package
o one-step ELISA
FGF23 c-terminal multi-matrix ELISA (BI-20702)
o for serum and plasma samples
o full validation package
o cited in +75 publications
Literature:
1. About Osteoporosis | International Osteoporosis Foundation
2. Management of postmenopausal osteoporosis. Reid IR, Bolland MJ. Endocr Rev. 2026 Jul 15;47(4):468-495. doi: 10.1210/endrev/bnag006. PMID: 41742825; PMCID: PMC13368380.
3. About Osteoporosis | World Osteoporosis Day
4. Epidemiology | International Osteoporosis Foundation